FZata, Inc. is an antibody technology company dedicated to developing antibody-based therapeutic and preventive medicines. Our strategy is to utilize the power of human immunity of antibodies for applications against diseases. Our mission is to create innovative medicines that make a real difference to health.
Our strategic goal is to become a renowned biotech company in the field of antibody-based medicines within 10 years.
This will be achieved through 3 stages:
Incubation stage: develop 2 preclinical products
Development stage: 1~2 products in clinical trial
Mature stage: well-developed pipeline with product in market